194 related articles for article (PubMed ID: 20838215)
1. Trazodone for the treatment of neuroleptic-induced acute akathisia: a placebo-controlled, double-blind, crossover study.
Stryjer R; Rosenzcwaig S; Bar F; Ulman AM; Weizman A; Spivak B
Clin Neuropharmacol; 2010; 33(5):219-22. PubMed ID: 20838215
[TBL] [Abstract][Full Text] [Related]
2. Treatment of neuroleptic-induced akathisia with the 5-HT2A antagonist trazodone.
Stryjer R; Strous RD; Bar F; Poyurovsky M; Weizman A; Kotler M
Clin Neuropharmacol; 2003; 26(3):137-41. PubMed ID: 12782915
[TBL] [Abstract][Full Text] [Related]
3. Trazodone as an Alternative Treatment for Neuroleptic-Associated Akathisia: A Placebo-Controlled, Double-Blind, Clinical Trial.
Shams-Alizadeh N; Maroufi A; Asadi Z; Rahmani K; Hassanzadeh K
J Clin Psychopharmacol; 2020; 40(6):611-614. PubMed ID: 33044356
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study.
Lerner V; Bergman J; Statsenko N; Miodownik C
J Clin Psychiatry; 2004 Nov; 65(11):1550-4. PubMed ID: 15554771
[TBL] [Abstract][Full Text] [Related]
5. Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study.
Miodownik C; Lerner V; Statsenko N; Dwolatzky T; Nemets B; Berzak E; Bergman J
Clin Neuropharmacol; 2006; 29(2):68-72. PubMed ID: 16614537
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study.
Baskak B; Atbasoglu EC; Ozguven HD; Saka MC; Gogus AK
J Clin Psychopharmacol; 2007 Jun; 27(3):289-94. PubMed ID: 17502777
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of trazodone in antipsychotic-induced akathisia resistant to conventional treatment.
Ribosa-Nogué R; Pagonabarraga J; Kulisevsky J
Parkinsonism Relat Disord; 2012 Aug; 18(7):902-3. PubMed ID: 22548708
[No Abstract] [Full Text] [Related]
8. Efficacy of low-dose mirtazapine in neuroleptic-induced akathisia: a double-blind randomized placebo-controlled pilot study.
Poyurovsky M; Epshtein S; Fuchs C; Schneidman M; Weizman R; Weizman A
J Clin Psychopharmacol; 2003 Jun; 23(3):305-8. PubMed ID: 12826992
[TBL] [Abstract][Full Text] [Related]
9. Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Fischel T; Hermesh H; Aizenberg D; Zemishlany Z; Munitz H; Benjamini Y; Weizman A
J Clin Psychopharmacol; 2001 Dec; 21(6):612-5. PubMed ID: 11763011
[TBL] [Abstract][Full Text] [Related]
10. Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia.
Janno S; Holi MM; Tuisku K; Wahlbeck K
Eur Neuropsychopharmacol; 2005 Jan; 15(1):39-41. PubMed ID: 15572272
[TBL] [Abstract][Full Text] [Related]
11. The 5-HT1D receptor agonist zolmitriptan for neuroleptic-induced akathisia: an open label preliminary study.
Gross-Isseroff R; Magen A; Shiloh R; Hermesh H; Weizman A
Int Clin Psychopharmacol; 2005 Jan; 20(1):23-5. PubMed ID: 15602112
[TBL] [Abstract][Full Text] [Related]
12. Zolmitriptan compared to propranolol in the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study.
Avital A; Gross-Isseroff R; Stryjer R; Hermesh H; Weizman A; Shiloh R
Eur Neuropsychopharmacol; 2009 Jul; 19(7):476-82. PubMed ID: 19342206
[TBL] [Abstract][Full Text] [Related]
13. Lack of efficacy of the 5-HT3 receptor antagonist granisetron in the treatment of acute neuroleptic-induced akathisia.
Poyurovsky M; Weizman A
Int Clin Psychopharmacol; 1999 Nov; 14(6):357-60. PubMed ID: 10565803
[TBL] [Abstract][Full Text] [Related]
14. 5-HT2A receptor antagonists for the treatment of neuroleptic-induced akathisia: a systematic review and meta-analysis.
Laoutidis ZG; Luckhaus C
Int J Neuropsychopharmacol; 2014 May; 17(5):823-32. PubMed ID: 24286228
[TBL] [Abstract][Full Text] [Related]
15. Cyproheptadine treatment in neuroleptic-induced akathisia.
Weiss D; Aizenberg D; Hermesh H; Zemishlany Z; Munitz H; Radwan M; Weizman A
Br J Psychiatry; 1995 Oct; 167(4):483-6. PubMed ID: 8829717
[TBL] [Abstract][Full Text] [Related]
16. Intravenous benztropine and propranolol challenges in acute neuroleptic-induced akathisia.
Sachdev P; Loneragan C
Clin Neuropharmacol; 1993 Aug; 16(4):324-31. PubMed ID: 8104097
[TBL] [Abstract][Full Text] [Related]
17. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Pyke RE; Clayton AH
J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
[TBL] [Abstract][Full Text] [Related]
18. Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial.
Poyurovsky M; Pashinian A; Weizman R; Fuchs C; Weizman A
Biol Psychiatry; 2006 Jun; 59(11):1071-7. PubMed ID: 16497273
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic agents in the treatment of acute neuroleptic-induced akathisia: open-label study of buspirone and mianserin.
Poyurovsky M; Weizman A
Int Clin Psychopharmacol; 1997 Sep; 12(5):263-8. PubMed ID: 9466160
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neuroleptic-induced akathisia with the 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study.
Poyurovsky M; Shardorodsky M; Fuchs C; Schneidman M; Weizman A
Br J Psychiatry; 1999 Mar; 174():238-42. PubMed ID: 10448449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
